SGTi-flex COVID-19 Ag Receives Provisional Authorisation from the Health Sciences Authority (HSA) in Singapore for In vitro Diagnostic (IVD) Use

Veredus Laboratories Pte Ltd “Veredus” is the appointed distributor of Sugentech, Inc. to market and sell SGTi-flex COVID-19 Ag.

Veredus has obtained Provisional Authorisation from Singapore Health Sciences Authority (HSA) to supply SGTi-flex COVID-19 Ag for use as an In vitro Diagnostic (IVD) test in Singapore. Veredus can now support healthcare institutions, private hospitals, medical clinics and clinical laboratories licensed under the Private Hospitals and Medical Clinics (PHMC) Act in Singapore.

SGTi-flex COVID-19 Ag is a one step, rapid Immunochromatographic Assay for the qualitative detection of specific antigens belonging to SARS-CoV-2 present in human nasopharyngeal (or oropharyngeal) swab specimen.

For more information, please visit our COVID-19 page or contact us at info@vereduslabs.com.